Login
$SNOA
$1.15 +$0.03 (2.68%) Live

Ownership

13F as of Q2 2026 · 4.8M shares outstanding

Who owns SNOA?

By type of holder
Institutions 100.0% Everyone else 0.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 9787.4%
BlackRock, Inc. 1942.0% · Vanguard Capital Management LLC 1538.8%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
2,362
-6 vs last qtr
Net shares bought
+44.0M
by institutions in Q2 2026
New / sold out
146 / 152
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Norges Bank NEW +14.4M
  • Price T Rowe Associates Inc /MD/ +10.0M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Jpmorgan Chase & Co −10.6M
  • Capital Research Global Investors SOLD OUT −2.6M

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Sonoma Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2026
+296116.3%
+637.74% a year
Each share's claim on the business
−100.0%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $2.05M
over 5 fiscal years
Diluted shares, split-adjusted
551850.7K1.7M2022: 569 shares'222023: 727.3K shares'232024: 1.4M shares'242025: 1.2M shares'252026: 1.7M shares'26
Buybacks Stock-based comp
$0$334.5K$669.0K2022 buybacks: $02022 stock comp: $382.0K'222023 buybacks: $02023 stock comp: $669.0K'232024 buybacks: $02024 stock comp: $516.0K'242025 buybacks: $02025 stock comp: $224.0K'252026 buybacks: $02026 stock comp: $255.0K'26

How patient are the owners?

Institutional shares by how long they've been held
5+ years82% 3–5 years2% 1–3 years12% Under 1 year4%
Quarterly turnover
7.6%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting SNOA on Form 13F
B
BlackRock, Inc.
Shares
93.0M
% of company
1941.99%
Change vs last qtr
+2.6M (+2.9%)
Held since
≤2021
VC
Vanguard Capital Management LLC
Shares
73.7M
% of company
1538.79%
Change vs last qtr
+2.1M (+3.0%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Sonoma Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting SNOA on Form N-PORT; together they hold 8152.7% of the company
VT
Position value
$3.43B
% of company
748.02%
% of the fund
0.15%
As of
June 30, 2026
V5
Vanguard Index Funds
Position value
$2.8B
% of company
610.28%
% of the fund
0.17%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Sonoma Pharmaceuticals Inc and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support